Quantum Biopharma annual operating expenses
2021
2022
2023
2024
2025
Quantum Biopharma Operating Expenses Growth & History (QNTM)
Quantum Biopharma's operating expenses was $15.3M for fiscal 2025.
View full Quantum Biopharma company overviewQuantum Biopharma annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $15.3M | −$833,886 | −5.17% |
| 2024 | 2024-12-31 | $16.1M | −$7.7M | −32.17% |
| 2023 | 2023-12-31 | $23.8M | −$3.6M | −13.27% |
| 2022 | 2022-12-31 | $27.4M | −$6.3M | −18.71% |
| 2021 | 2021-12-31 | $33.7M | — | — |
Quantum Biopharma quarterly operating expenses
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.3M | −$2.6M | −53.00% |
| Q1 2026 | 2026-03-31 | $2.9M | −$487,931 | −14.36% |
| Q4 2025 | 2025-12-31 | $2.4M | −$3.9M | −61.97% |
| Q3 2025 | 2025-09-30 | $4.7M | $497,057 | +11.89% |
| Q2 2025 | 2025-06-30 | $4.9M | $1.4M | +40.41% |
| Q1 2025 | 2025-03-31 | $3.4M | $1.1M | +50.50% |
| Q4 2024 | 2024-12-31 | $6.2M | — | — |
| Q3 2024 | 2024-09-30 | $4.2M | $869,193 | +26.24% |
| Q2 2024 | 2024-06-30 | $3.5M | −$5.4M | −60.86% |
| Q1 2024 | 2024-03-31 | $2.3M | — | — |
| Q3 2023 | 2023-09-30 | $3.3M | — | — |
| Q2 2023 | 2023-06-30 | $8.8M | — | — |
Quantum Biopharma operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Quantum Biopharma's operating expenses decreased from $33.7M to $15.3M, a change of −$18.4M. The latest reported quarter, Q2 2026, shows $2.3M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Quantum Biopharma source filings ↗